Professor Datin Dr. Hapizah Md Nawawi, is a Professor and Senior Consultant in Chemical Pathology and Metabolic Medicine at the Faculty of Medicine, Universiti Teknologi MARA (UiTM), Malaysia; and Founding Director and Principal Fellow of the Institute of Pathology, Laboratory and Forensic Medicine (I-PPerForM), one of UiTM Centres of Excellence (CoE). Prof Hapizah’s research niche areas are dyslipidaemias particularly molecular aspects of Familial Hypercholesterolaemia (FH), atherosclerosis, and coronary heart disease (CHD) prevention. The focus is on translational research with the molecules-to-man concept, ranging from molecular, in-vitro fundamental science to in-vivo animal and human studies, including clinical trials and epidemiological studies, which have accrued impactful output and outcome. Novel knowledge generation, advancement, and dissemination had been culminated with over 140 journal publications (40 in high impact JCRQ1/Q2), 500 abstracts in journal/proceedings, 19 books/chapters-in-books with high cumulative citations, (3033/1623/5396 in Publons/Scopus/Google Scholar). These have benefited the related professions, stakeholders, and society. The three most recent high-impact publications in The Lancet (IF 79.321)/ Atherosclerosis (IF), alongside many renowned researchers representing more than 60 countries worldwide, have gained visibility of Malaysia's research on the world map.